Our Experts
Centers
Center for Innovation in Global Health
Developing scalable solutions to global health’s toughest challenges.
Learn MoreCenter for HIV and Infectious Disease Policy
Building robust and equitable legal, regulatory, and policy responses to the epidemics of HIV and hepatitis in the United States.
Learn MoreCenter for Global Health Policy and Politics
Focusing at the intersection of public health, law, policy, and governance.
Learn MoreProjects
Measuring HIV Prevention
Bringing clarity to the measurement of HIV prevention programs and driving these programs toward greater impact.
Learn MoreEthics of Big Data for Disease Prevention
Supporting countries in more efficient resource allocation decisions by improving information and driving programs toward greater impact.
Learn MoreBlantyre Prevention Strategy
Developing a replicable model for effective HIV prevention by defining, optimizing, and embedding core capabilities to successfully end the epidemic and strengthen health security.
Learn MoreImproving Laws and Policies for Sex Workers
Exploring the impact of and recommending reforms to laws and policies that improve the health and well-being of sex workers in Washington, D.C.
Learn MoreHIV Prevention Policy Project
Engaging with people living with HIV, researchers, and federal, state, and local policymakers to understand and advance effective HIV prevention in the United States.
Learn MoreHIV Policy Project
Working to maintain and bolster the U.S. response to the domestic HIV epidemic, including efforts to sustain, advance, and adapt the Ryan White HIV/AIDS Program.
Learn MoreCommunity-Led Monitoring of Health Services
Building accountability and improving the quality of health services through community-led, routine data collection and evidence-based advocacy.
Learn MoreHIV Policy Lab
Tracking, measuring, and improving HIV-related law and policy environment in countries around the world.
Learn MoreAddressing Policy Barriers to PrEP Uptake and Planning for Long-Acting Agents
Examining critical policy issues that impact access, availability, and acceptability of pre-exposure prophylaxis (PrEP) and long-acting agents for HIV treatment and PrEP.
Learn MoreBlueprint for HIV Biomedical Prevention Project
Examining the status of biomedical HIV prevention research and implementation in the United States.
Learn MorePress See All
Statement
September 13, 2024
In The News
August 10, 2024
In The News
August 1, 2024
In The News
July 26, 2024
Publications See All
Op-Ed
September 19, 2024
Quick Take
September 10, 2024
Big Ideas in Brief
August 19, 2024
Big Ideas
August 19, 2024